Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine for Patients With Malignancy at the Comprehensive Cancer Center of Wake Forest University

NCT02566421 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT02566421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02566421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine for Patients With Malignancy at the Comprehensive Cancer Center of Wake Forest University
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2015
Completion date
August 31, 2017
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic neoplasm, recurrent neoplasm, recurrent non-small cell lung carcinoma, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer, unresectable malignant neoplasm